BIO Commends Senate for Approval of User Fee Package FDASIA headed to President for signature into law – CNBC
WASHINGTON, Jun 26, 2012 (BUSINESS WIRE) -- Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S ...
Subscribe to LegalLaw247.Com Newsletter